These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16211896)

  • 1. [Treatment and rehabilitation of myopathies linked to sex in relation to prognosis].
    Rideau Y
    Ann Pediatr (Paris); 1977 Nov; 24(11):773-9. PubMed ID: 16211896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Respiratory management of patients with Duchenne muscular dystrophy].
    Ishikawa Y
    No To Hattatsu; 2014 Mar; 46(2):103-7. PubMed ID: 24738185
    [No Abstract]   [Full Text] [Related]  

  • 3. Enigmatic conflict of clinical and molecular diagnosis in Duchenne/Becker muscular dystrophy.
    Dubowitz V
    Neuromuscul Disord; 2006 Dec; 16(12):865-6. PubMed ID: 17118656
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
    Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
    Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phenotypic heterogeneity of Duchenne myopathy and prognosis criteria].
    Desguerre I; Mayer M; Christov C; Leturcq F; Chelly J; Gherardi RK
    Arch Pediatr; 2009 Jun; 16(6):681-3. PubMed ID: 19541128
    [No Abstract]   [Full Text] [Related]  

  • 6. [Duchenne muscular dystrophy: classification of the respiratory failure and study on the prognosis in the terminal stage based on arterial CO2 pressure].
    Motomura M; Kanazawa H; Shibuya N
    Rinsho Shinkeigaku; 1988 Sep; 28(9):992-5. PubMed ID: 3149921
    [No Abstract]   [Full Text] [Related]  

  • 7. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
    Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
    Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "My son is still walking": stages of receptivity to discussions of advance care planning among parents of sons with Duchenne muscular dystrophy.
    Erby LH; Rushton C; Geller G
    Semin Pediatr Neurol; 2006 Jun; 13(2):132-40. PubMed ID: 17027863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory support for the severely handicapped child with neuromuscular disease: ethics and practicality.
    Simonds AK
    Semin Respir Crit Care Med; 2007 Jun; 28(3):342-54. PubMed ID: 17562504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Muscular magnetic resonance imaging for evaluation of myopathies in children].
    Peters SA; Köhler C; Schara U; Hohendahl J; Vorgerd M; Nicolas V; Heyer CM
    Klin Padiatr; 2008; 220(1):37-46. PubMed ID: 18098096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical approach in myopathies].
    Urtizberea JA
    Soins; 2005 Sep; (698):28-30. PubMed ID: 16220888
    [No Abstract]   [Full Text] [Related]  

  • 12. A 2009 perspective on the 2004 American Thoracic Society statement, "respiratory care of the patient with Duchenne muscular dystrophy".
    Finder JD
    Pediatrics; 2009 May; 123 Suppl 4():S239-41. PubMed ID: 19420152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic toe-walking.
    Babb A; Carlson WO
    S D Med; 2008 Feb; 61(2):53, 55-7. PubMed ID: 18432151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electromyographic pattern in Duchenne and Becker muscular dystrophy. Part II. Electromyographic pattern in Becker muscular dystrophy in comparison with Duchenne muscular dystrophy.
    Emeryk-Szajewska B; Kopeć J
    Electromyogr Clin Neurophysiol; 2008; 48(6-7):279-84. PubMed ID: 18837193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome measures in Duchenne muscular dystrophy: are we ready for the new therapeutic era?
    Merkies IS; Faber CG
    Neuromuscul Disord; 2009 Jun; 19(6):447. PubMed ID: 19482474
    [No Abstract]   [Full Text] [Related]  

  • 16. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.
    Mayhew JE; Florence JM; Mayhew TP; Henricson EK; Leshner RT; McCarter RJ; Escolar DM
    Muscle Nerve; 2007 Jan; 35(1):36-42. PubMed ID: 16969838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive respiratory insufficiency in the absence of cardiac disease in late-stage Duchenne muscular dystrophy.
    Finsterer J; Stöllberger C; Meng G
    Respir Care; 2013 Mar; 58(3):e28-30. PubMed ID: 22781000
    [No Abstract]   [Full Text] [Related]  

  • 19. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.
    Desguerre I; Mayer M; Leturcq F; Barbet JP; Gherardi RK; Christov C
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):762-73. PubMed ID: 19535995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Respiratory management of muscular dystrophies].
    Paulus J
    Soins; 2005 Sep; (698):37-9. PubMed ID: 16220893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.